This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Telithromycin less costly than clarithromycin for CAP. Pharmacoecon. Outcomes News 420, 3 (2003). https://doi.org/10.1007/BF03276485
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276485